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The root of word probiotic comes from the Greek word and means “pro-life”. “Pro” meaning promoting and “biotic” means life [1]. The World Health Organization’s (WHO) 
2001 definition of probiotics is “live microorganisms which, 
when administered in adequate amounts, confer a health benefits 
on the host” [2]. The beneficial effects of probiotics are seen in 
various diseases such as acute infectious diarrhea, antibiotic-
associated diarrhea, necrotizing enterocolitis, irritable bowel 
syndrome, celiac disease, Helicobacter pylori etc., [3]. Probiotics 
act in so many ways such as, favorably affect the host by local 
and/or immune modulation pathway, compete the pathogens for 
nutrients in gut, produce bacteriocin which act as local antibiotics 
against pathogens, are able to decrease enteroaggregative 
Escherichia coli virulence factor, inhibit pathogen growth by 
producing lactic and acetic acid resulting in lowering the luminal 
pH, stimulate mucin production and maintain integrity of mucosal 
barrier etc., [3].
Diarrhea is one of the major causes of morbidity and mortality 
in developing world. Acute diarrhea is defined as the abrupt onset 
of 3 or more loose stools per day and lasts no longer than 14 days; 
chronic or persistent diarrhea is defined as an episode that lasts 
longer than 14 days [4]. Oral rehydration salts (ORS) and zinc 
have a definite role in the treatment of diarrhea, but the role 
of probiotics still needs more studies. There are lots of studies 
done in the Western world which shows the beneficial effect 
of probiotics in acute diarrhea, antibiotic-associated diarrhea, 
clostridium difficile infection other diseases also, but Indian 
studies are very limited. According to the American Academy 
of Pediatrics several randomized clinical trials in developed 
countries indicate that probiotics reduce the number of diarrheal 
stools and the duration of diarrhea by approximately 1 day [5]. As 
far as, Indian setting is concerned, there is no sufficient evidence 
to recommend the probiotics in treatment of acute diarrhea [6]. 
Objective of our study was to determine the effect of probiotics in 
acute diarrhea among the Indian children of rural area as diarrhea 
accounts for over 20% of all deaths in under-5-children [7].
MATERIAL AND METHODS
A randomized control trial was done in the Department of 
Pediatrics, Uttar Pradesh University of Medical Sciences, 
Saifai, and Etawah from January 2015 to April 2016. Children 
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admitted to pediatrics ward with complaint of acute diarrhea, 
age group 6 months-5 years were enrolled in the study. Acute 
diarrhea is defined as more than 3 loose or watery stools in the last 
24 h and duration of diarrhea is < 48 h. Children who had severe 
dehydration [8], severe malnutrition (weight for age 51-60% of 
50th percentile as per Indian academy of pediatrics classification 
of malnutrition) [9], dyselectrolytemia, diarrhea not improving in 
14 days, history of allergy to probiotics, acute abdomen or colitis, 
probiotic or symbiotic intake in the last 1 month, probiotic or 
prebiotic containing foods intake in form of curd, dark chocolate 
yoghurt, fermented barley, pickles, etc., in the previous 48 h, 
chronic and persistent diarrhea, patients who need antibiotics and 
other drugs during the treatment period, patient suffering from 
any chronic or severe respiratory, cardiovascular, central nervous 
system, gastrointestinal or other systemic diseases, already taken 
antibiotic or anti-diarrheal drug for existing episode of diarrhea, 
patients whose parents or attendant did not give informed consent 
were excluded from the study.
Sample size has been calculated from the data shown in the 
previous study from south India. In that study, mean duration of 
diarrhea was found to be 7.67±4.76 days in the control group and 
the mean difference in duration of diarrhea between study and 
control group was 2.15 days [10]. As in our study, outcome is 
quantitative data; accordingly, we need to study 77 experimental 
and 77 controls to be able to reject the null hypothesis with the 
predictive power of 80%, with an alpha error of 5% [11]. We took 
total 195 patients, of which 94 are in the control group and 101 in 
the study group.
After taking approval from the Institutional Ethics Committee, 
children fulfilling the inclusion criteria were enrolled in the study. 
Written and informed consent of parents were taken. Baseline 
data included name, age, sex, address, duration, and frequency of 
diarrhea was taken. Proper history, anthropometric examination, 
general and systemic examination were done, and investigation 
such as complete blood count (to rule out infection) and serum 
electrolytes were done in every patient. Stool culture was done 
if required.
Subjects were randomized to intervention following simple 
randomization procedure with the computer-generated random 
numbers. Children were randomized to Group A, those received 
study drug in white paper packing and Group B which received 
identical placebo for 1 week. Placebo was also provided in 
identical white paper packing of same size and quantity as the 
study drug. It was ensured that when study drug or placebo was 
mixed with 10 ml of water, they look identical. Proper coding 
was done and treatment given accordingly. As per the allocation, 
drugs were prescribed to the patients by a pediatrician. Treating 
pediatricians were aware of allocation arm, but attendants of 
patients, staff nurses who provided the drug at bed side, outcome 
assessor who was one of the senior residents of our department 
and data analysts were kept blinded to the allocation.
All patients were treated with WHO ORS required as per the 
WHO criteria for no and some dehydration or intravenous fluid 
if needed, till the resolution of diarrhea and zinc 20 mg/day for 
14 days. Apart from this standard treatment, study group was given 
probiotic sachet constituting Streptococcus faecalis 30 million, 
Clostridium butyricum 2 million, Bacillus mesentericus 1 
million, Lactobacillus sporogenes 50 million twice a day after 
mixing in 10 ml of water while the control group was given only 
standard treatment of diarrhea and placebo mixed in 10 ml of 
water.
Records were kept for frequency and consistency of diarrhea 
and vomiting for every 24 h till diarrhea subsided. Each 
study day was defined as 24 h counted for the administration 
of the 1st dose of the study drug. Daily weight charting and 
assessment of dehydration were done and any adverse effects 
such as vomiting, constipation, bloating, pain abdomen, and 
anaphylactic reaction were noted. Patients were assessed daily 
for frequency and consistency of stool. Duration of diarrhea 
was counted from the day of admission to the resolution of 
diarrhea. Passage of 2 consecutive formed stools and/or having 
no stool passing till 12 h was considered as a resolution of 
diarrhea patients were discharged one day after the resolution 
of diarrhea.
Statistical analysis was done using SPSS software 21 Version 
test and Independent sample test or Mann-Whitney U-test were 
used for statistical analysis.
RESULTS
Total 220 patients were screened for eligibility criteria. 13 patients 
were excluded as they were not fulfilling the inclusion criteria. 
207 patients were randomized to control and study group, in which 
101 patients were assigned to the control group and 106 patients 
to the study group. From control group, 7 patients and from 
study group, 5 patients were excluded due to various regions. 
Total 195 patients completed the study. Out of these, 94 (48.2%) 
were treated with standard treatment without probiotics (control 
group), while 101 (51.8%) patients were given probiotics apart 
from the standard treatment of diarrhea (study group) (Fig. 1)
Both the groups were comparable with reference to age, 
weight, gender, height and severity of disease (p>0.05) as shown 
in Table 1.
The mean duration of diarrhea was found to be significantly 
reduced in the study group (4.60±0.88 days) as compared to the 
control group (5.31±0.98 days) (p<0.001). So study group had 
earlier recovery in comparison to control group (Table 2). No 
significant side effects like bloating, stomach ache, vomiting; 
constipation and anaphylactic reaction were seen in any group. 
The number of stools per day was significant less in the treatment 
Table 1: Demographic characteristics of the study population
Characteristic Study group Control group
Number of patients 101 94
Male:Female 1.19:1 0.91:1
Age in months (mean±SD) 18.22±15.03 18.31±15.18
Weight in kg (mean±SD) 8.84±3.76 8.89±3.63
Height in cm (mean±SD) 73.4±14.76 72.7±15.04
SD: Standard deviation
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group as compared to the control group, starting from 24 h of 
therapy (Table 3).
As per-protocol analysis, maximum recovery from diarrhea 
in the study group was seen on 4th and 5th day, 80 (79.20%) out 
of 101 patients were recovered, while in control group most of 
the patients recovered on day 5th and 6th i.e.,  70 (74.46%) out of 
94 patients (Fig. 2).
DISCUSSION
Probiotics reported to significantly reduce the duration of acute 
diarrhea in children. Our study aimed to know the effects of 
probiotics on acute diarrhea in children living in rural area. We 
found that the duration of diarrhea was significantly reduced in the 
study group. The beneficial effects of probiotics in acute diarrhea 
have been always controversial despite few Western studies 
have shown their beneficial effect. Possible mechanisms that 
have played a role in reducing the duration of acute diarrhea are 
immune modulation pathway, compete the pathogen for nutrients 
in gut, bacteriocin production, a decrease in enteroaggregative 
E. coli virulence factor, lowering the luminal pH, etc., [3].
In Indian setting where the breastfeeding rates are high, and 
the microbial colonization of the gut is different [6], our study can 
strengthen the role of probiotic in diarrhea. In a study, Applegate 
et al. also reported that probiotics may be efficacious in reducing 
diarrhea duration and stool frequency during a diarrhea episode [12]. 
Burande and Burande compared the efficacy of Saccharomyces 
boulardii strain in the treatment of acute diarrhea in Indian children 
and found that the mean duration of diarrhea for the study group 
was 3.4±1.4 days and for control group was 5.5±2.1 days (Z value 
13 Patients were excluded as 
not fullling the inclusion
 criteria
207 patients were randomized to control and study group
Figure 1: Flowchart showing the outcome in study population
Table 2: Duration of diarrhea in study and control group
Intervention groups Number of patients Mean duration of diarrhea (days) SD Standard error of mean p value
Control group 94 5.31 0.98 0.101 <0.001
Study group 101 4.60 0.88 0.088
SD: Standard deviation
Vol 4 | Issue 3 | Jul - Sep 2017 Indian J Child Health 305
Kumar et al. Probiotics in acute diarrhea: A randomized control trial
4.9). In our study also, mean duration of diarrhea in the study group 
is 4.60±0.88 days and control group 5.31±0.98 days (p<0.001). 
The difference in duration of diarrhea in both the studies may be 
because of the different strains of probiotics were used [13].
Bhat and Adhisivam evaluated the safety, efficacy, and 
tolerability of symbiotic on reducing and frequency and duration 
of acute diarrhea children of age group 6 months-10 years. In their 
study, mean duration of diarrhea was 5.52±1.98 days in the study 
group in comparison to 7.67±4.77 days in control group which is 
comparable to our study. The difference in duration of diarrhea may 
be due to the difference in sample size and age of the children [10].
According to the article by Ciorba, the American Academy of 
Pediatrics states that the probiotics for preventing acute infectious 
diarrhea are not universally endorsed, but it acknowledges that 
they may have a role in special circumstances [14]. Meta-analysis 
done by Salari et al. concluded that probiotics may reduce the 
duration of diarrhea and fever in children, but their exact efficacy 
in the treatment of diarrhea is not obvious yet [15].
The strength of our study was its pinpointed approach 
to see the effect of probiotics in Indian rural children with 
defined strain, dose and also with zinc as per the world health 
organization recommendations. Confounding factors such as 
severe dehydration, severe malnutrition, probiotic or prebiotic 
containing food intake, any chronic illness, etc., were removed to 
increase the strength of our study. The limitation of our study was 
no follow-up after discharge. The effect of probiotics in dysentery 
and in severe dehydration was also not investigated. Further, 
studies are needed to resolve these limiting issues.
CONCLUSION
The probiotics significantly reduce the duration of acute diarrhea 
in children. Reduction of the duration of diarrhea of about 1 day 
by probiotics use is helpful to satisfy the anxiety of parents but as 
far as physicians are concern the decision of use of probiotics in 
diarrhea should be individualized.
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Figure 2: Number of patients recovering from diarrhea in both 
groups each day
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Table 3: Number of stools after 24 h, 48 h and 72 h of diarrhea
Parameter Group n mean±SD p-value
Number of stools per day
After 24 h
Study 101 9.66±2.71 <0.005
Control 94 10.97±3.69
Number of stools per day
After 48 h
Study 101 7.17±2.28 <0.0001
Control 94 8.90±2.88
Number of stools per day
After 72 h
Study 101 5.04±2.00 <0.0001
Control 94 7.19±2.49
